Benzinga | Jan 15, 2021 07:38AM EST

Deutsche Bank Initiates Coverage On Novo Nordisk with Buy Rating

Deutsche Bank analyst Emmanuel Papadakis initiates coverage on Novo Nordisk (NYSE:NVO) with a Buy rating.